NetworkNewsBreaks

ThursdayOct 07, 2021 2:32 pm

NetworkNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) Announces Entry into Strategic LOI

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent (“LOI”) for the formation of a commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI’s affiliate, Kingston Aluminum Technologies Inc. (“KAT”) will provide custom designed aluminum packaging for Sproutly’s products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly’s formulations made using ingredients produced by the proprietary APP cannabis processing technology. “This relationship will allow us to launch our beverages made…

Continue Reading

ThursdayOct 07, 2021 2:12 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) Engages Clinipace in Pursuit of FDA Approval for Therapeutics

Clearmind Medicine (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announced a strategic partnership. Clearmind has engaged Clinipace Incorporated, a full-service contract research organization (“CRO”), to advise the company in its pursuit of Food and Drug Administration (“FDA”) approval for its therapeutics. “Moving any drug through the FDA approval process requires deep expertise and meticulous attention to detail; this is particularly true for psychedelics,” said Adi Zuloff-Shani, PhD., CEO of Clearmind. “We chose Clinipace as our CRO as they have facilitated dozens of…

Continue Reading

ThursdayOct 07, 2021 1:50 pm

NetworkNewsBreaks – DSG Global Inc. (DSGT), Imperium Motor Add INDI EV Crossover Sedan to LA Auto Show Lineup

DSG Global (OTCQB: DSGT) today announced that its electric vehicle division, Imperium Motor Company, will be showcasing the new INDI EV fully electric crossover sedan. “We are pleased to announce the inclusion of the new INDI crossover sedan to our lineup at the Los Angeles International Auto Show. This will be the first major auto show event for this highly anticipated fully electric vehicle. This extremely well-equipped all-new vehicle fits nicely into our Imperium product lineup along with the Imperium SEV, TradePro Vans and other EV models,” said Rick Curtis, CEO of Imperium Motor Corp. “INDI is based in Los Angeles…

Continue Reading

ThursdayOct 07, 2021 1:15 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Applies to Uplist to the Toronto Stock Exchange

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced that it has applied to list (“uplist”) its common shares on the Toronto Stock Exchange (“TSX”) with the view of increasing access to capital markets. According to the update, the uplisting is subject to the approval of the TSX in accordance with its original listing requirements. The TSX has not conditionally approved PlantX’s application and there is no assurance that it will approve the listing application or that PlantX will complete the uplisting as proposed. “Uplisting our shares to the TSX will mark a valuable milestone that will highlight PlantX’s impact…

Continue Reading

ThursdayOct 07, 2021 12:55 pm

NetworkNewsBreaks – StorEn Technologies Inc. Leveraging Shareholder Support on Path to Volume Manufacturing

StorEn Technologies, a developer of evolutionary vanadium flow batteries with a disruptive patent-pending, all-vanadium flow battery technology, recently announced that Accelerate New York Seed Fund (“ANYSeed”) has become a shareholder. “Over three years ago, in March of 2019, we raised funds from ANYSeed and issued them a convertible note after receiving the financing. If you’re not familiar with how convertible notes work, they are a popular fundraising instrument, a hybrid of debt and equity. They are structured as loans with the option of converting to equity, as opposed to requesting the repayment of the principal plus accrued interest,” a recent…

Continue Reading

ThursdayOct 07, 2021 12:49 pm

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) to Present at KCSA Psychedelics Virtual Investor Conference

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, today announced that its president and CEO Kelsey Ramsden will present virtually at the KCSA Psychedelics Investor Conference, which will be held Oct. 13-14, 2021, at VirtualInvestorConferences.com. Ramsden’s presentation is scheduled to begin at 12 p.m. ET on Oct. 13, 2021. The live, interactive online event is designed to enable investors to ask presenting companies questions in real-time. Interested parties should visit https://nnw.fm/80oP3 to register for and access the event. It is recommended that investors pre-register and run the online system check to expedite…

Continue Reading

ThursdayOct 07, 2021 12:41 pm

NetworkNewsBreaks – Why StraightUp Resources Inc. (CSE: ST) Is ‘One to Watch’

StraightUp Resources (CSE: ST) is engaged in the business of mineral exploration and the acquisition of mineral property assets across North America. “The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals,” reads a recent article. “The mission of StraightUp Resources is to maximize shareholder wealth…

Continue Reading

ThursdayOct 07, 2021 12:31 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Collaboration with University of Wisconsin Researchers to Evaluate TRP-8803

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, this morning announced a collaboration to support clinical pharmacology studies for Tryp’s proprietary drug product TRP-8803. Dr. Paul Hutson, Professor of the Pharmacy Practice Division at the University of Wisconsin-Madison School of Pharmacy and Dr. Christopher Nicholas, Assistant Professor at the University of Wisconsin School of Medicine, will serve as investigators on the clinical pharmacology studies to assess the pharmacokinetics and safety of TRP-8803 in healthy, volunteer patients. The completion of the studies is anticipated to deliver additional regulatory support…

Continue Reading

ThursdayOct 07, 2021 12:24 pm

NetworkNewsBreaks – Moon Equity Holdings Corp.’s (MONI) Business Model Centers Around Building Strategic, Diversified Portfolio

Moon Equity Holdings (OTC: MONI) is an investment company focusing on strategic acquisitions across fintech, crypto, precious metals and real estate sectors. The company’s business philosophy centers around providing shareholders with a well-diversified acquisition portfolio focused on income-generating opportunities that produce long-term gains. “MONI has recently undertaken a spate of corporate actions designed to influence its business model going forward. Earlier this year, the company acquired Royal Costino LLC as a wholly owned subsidiary for its newly created mining division. The acquisition is the first step for the company in two planned mining acquisitions this year, with the Royal Costino…

Continue Reading

ThursdayOct 07, 2021 11:54 am

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Achievement of Adelia Milestones

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has announced that Adelia Therapeutics Inc., a wholly-controlled subsidiary of Cybin, has achieved the milestones identified as “Year 2 Q1 (i)-(iii).” According to the update, the milestones were contemplated by the terms of a contribution agreement dated Dec. 4, 2020, among Cybin, Cybin Corp., Cybin US Holdings Inc. (the “acquiror”), a wholly controlled subsidiary of Cybin, and all previous shareholders of Adelia. Per the terms of the agreement, Class B common shares in the capital of the acquiror shall be issued to Adelia shareholders, in satisfaction…

Continue Reading